Adani Wilmar has delivered strong double-digit volume growth at 25% for the first quarter ended June. However, sales declined 15%, mainly due to sharp drop in edible oil prices.
Glenmark Pharmaceuticals that owns 82.85 per cent stake in Glenmark Life Sciences may sell the API developer and manufacturer in bid to deleverage, as per the report.
Foreign institutional investors (FIIs), which offloaded shares worth Rs 1.10 lakh crore in Q4FY22, were also seen buying selective stocks on Dalal Street during the quarter gone by.
On Wednesday, the benchmark indices ended lower despite positive global cues. Sensex closed 145 points lower at 57,996 and Nifty lost 30 points to end at 17,322.
Solara reported a net loss of Rs139.87 crore for the quarter ended December 2021 as compared to a profit of Rs65.80 crore during the previous corresponding quarter.